Allergan Aesthetics launches HArmonyCa with Lidocaine, its first dual-effect Hybrid Injectable
---- The dual-effect Hybrid Injectable contains two active ingredients, hyaluronic acid (HA) - a well-known ingredient found in facial fillers1 - and calcium hydroxyapatite (CaHA) which is known to help stimulate collagen production2,3 ---
---- In one single injection HArmonyCaTM offers the potential of an immediate lift4§§ effect from HA and sustained collagen stimulation from CaHA5††, and may be suitable for people exhibiting signs of ageing2----
---- Over 90% [91.6%, N=162] of patients reported improvement in general appearance of facial areas following treatment with HArmonyCaTM6§# ----
MONACO, April 1, 2022 /PRNewswire/ -- Today, at the Aesthetic & Anti-Aging Medicine World Congress (AMWC) in Monaco Allergan Aesthetics, an AbbVie Company, a global leader in medical aesthetic treatments and maker of Juvéderm facial fillers and CoolSculpting body contouring treatment, announces its entry into the category of Hybrid Injectables with the launch of HArmonyCa with Lidocaine.2
Exploring new possibilities
As market leader Allergan Aesthetics looks to further develop this exciting category of Hybrid Injectables by introducing its first dual-effect product, which combines the two active ingredients - hyaluronic acid (HA) and calcium hydroxyapatite (CaHA) - in one injection.2 The treatment may offer the improvement of an immediate lift4§§ from HA, plus a sustained lifting effect from CaHA causing new collagen production.5†† In a late follow- up satisfaction cohort (N=45) of a post marketing clinical follow up of safety and performance of HArmonyCaTM (N=162), a majority of patients reported a high user satisfaction (mean 4.1 out of 5) for overall satisfaction, and likeliness to repeat similar treatment up to 19 months after treatment with HArmonyCaTM.6 §||||
The science
HArmonyCaTM is intended for facial soft tissue augmentation via injection into deep dermal and sub-dermal layers.2 It is a dual-effect Hybrid Injectable containing:
- Cross-linked HA gel, which may provide an immediate lifting effect that is mouldable,7 allowing a qualified aesthetic practitioner to adjust the implant shape following administration2,8
- CaHA microspheres, which support the body's own collagen production by inducing the formation of collagen fibres2,3,9
The hyaluronic acid particles work deep within the skin, where they help plump it for an immediate lifting effect,7† while the CaHA microspheres work to support the body's own collagen production, so new collagen fibres start to grow.3,9 Newly formed collagen fibres may be present as early as one week following treatment.5††
0 Kommentare
| 
